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Monoclonal hybridoma ntibodies directed against RNA polymerase from E. coli have been obtained. 
Only a few have been found to inhibit the enzyme activity. Antibodies produced by two clones, PYN-1 
and PYN-2, inhibit RNA polymerase at the stage of RNA chain elongation. The PYN-1 antibodies react 
with the ,&-subunit of the enzyme. The PYN-2 antibodies react with the &subunit and with its 130 kDa 
amber fragment. 
RNA polymerase RNA chain elongation 
1. INTRODUCTION 
Bacterial RNA polymerases are large, complex 
oligomeric enzymes with the subunit composition, 
d&flu. The specific roles of these subunits is not 
yet clear. One approach to unravelling these roles 
is the use of antibodies as specific probes [l-3]. An 
obvious advantage of using monoclonal antibodies 
is their specificity for a single antigenic determi- 
nant [4]. Such antibodies have already been ob- 
tained against RNA polymerases from eukaryotic 
organisms [5-71. Here, we describe the prepara- 
tion and preliminary characterization of mono- 
clonal antibodies inhibiting RNA polymerase from 
Escherichia coli. 
2. MATERIALS AND METHODS 
RNA polymerases from E. coli and Pseudo- 
monasputida were purified by the method in [8] as 
described [9]. RNA polymerase activity was assayed 
as in [2]. 
BALB/c mice were immunized with 100 tg puri- 
fied core RNA polymerase in a saline solution, 
intraperitoneally. One month later, they were 
boosted in the same way. Three days later the 
spleens were removed for fusion. The fusion with 
MonocIonal antibody Immunoblotting 
the cell line P3IAg8.653 [lo] and cloning were per- 
‘formed as in [ll]. 
Screening of hybridoma lines was performed by 
radioimmunoassay in U-bottomed 96-well flexible 
microtiter plates. 
For immunoblotting RNA polymerase subunits 
were separated on an acetate-cellulose gel in 6 M 
urea as in [12] and transferred to a nitrocellulose 
sheet by pressing. Then the nitrocellulose was 
treated with 5% human serum albumin in Tris- 
buffered saline, cut in strips, reacted for 1 h with 
monoclonal antibody preparations, washed, re- 
acted with rabbit anti-mouse C, peroxidase-con- 
jugated antibodies, washed and developed with 
3,3diaminobenzidine in hydrogen peroxide essen- 
tially as in [13]. 
3. RESULTS 
We have performed one fusion using spleens 
from 3 mice immunized with purified core RNA 
polymerase from E. coli. Growth of hybrid cells 
was observed in 270 out of 512 initial culture wells. 
44 cell lines giving the highest radioimmunoassay 
counts were propagated further. Their supernatant 
culture fluids were screened for an ability to inhibit 
RNA polymerase activity. Only 3 hybridoma lines 
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were found to produce inhibiting antibodies. These 
lines were subcloned and antibodies secreted by 2 
clones, PYN-1 and PYN-2, were studied in greater 
detail. 
A competitive radioimmunoassay showed PYN-1 
and PYN-2 clones to secrete antibodies of the 
IgG2b type. The PYN-1 and PY’N-2 antibodies 
neither reacted with nor inhibited RNA polymer- 
ase from Pseudomonas putida. This shows that the 
inhibitory action is due to specific interaction of 
the antibody and the enzyme, and not to contami- 
nations. To determine the stage of transcription af- 
fected, we added antibodies into reaction mixtures 
either before the binding of RNA polymerase to 
DNA or after the beginning of RNA synthesis. 
Fig.1 shows that the PYN-1 antibodies obtained 
from ascites fluid by ammonium sulfate precipita- 
tion, inhibit RNA polymerase activity equally well 
in both cases. The same results were obtained for 
the PYN-2 antibodies. These data clearly show 
that the antibodies studied can inhibit RNA poly- 
merase during RNA chain elongation but do not 
exclude the possibility of their affecting the pre- 
ceeding stages of transcription. 
Fig.1. Inhibition of RNA polymerase activity by the 
PYN-1 antibodies: (0) antibodies were added to assay 
mixtures before the binding of RNA polymerase 
(20 pg/ml) to DNA; (A) antibodies were added to assay 
mixtures 2 min after the beginning of RNA synthesis. To 
prevent reinitiation rifampicin (10 pg/ml) was also 
added. 
Fig.2. Interaction of antibodies with RNA polymerase 
subunits after their separation on acetate cellulose gel 
and transfer to nitrocellulose: (a) PYN-1 antibodies; 
(b) polyclonal antibodies; (c) PYN-2 antibodies. 
To identify the subunits of RNA polymerase 
which contain the antigenic determinants for the 
monoclonal antibodies we reacted the antibodies 
with individual subunits separated on an acetate 
cellulose gel and immobilized on nitrocelluloase. 
Fig.2 shows that the PYN-1 antibodies react with 
the ,B’-subunit while PYN-2 antibodies react with 
the p-subunit. 
4. DISCUSSION 
We have shown rabbit polyclonal antibodies 
against the fi- and P’-subunits (but not against the 
a-subunit) to inhibit RNA polymerase activity [2]. 
This fact suggested the involvement of the fl- and 
,&‘-subunits in the catalytic function of RNA poly- 
merase. These results confirm and extend this con- 
clusion, which is consistent both with genetic 
[9,15] and with affinity-labelling data [16,17]. The 
localization of the relevant antigenic determinants 
within the polypeptide chains of the ,8- and 
fl’-subunits will be useful for identifying the RNA 
polymerase domains involved in RNA chain elon- 
gation. So far we have shown that the PYN-2 anti- 
bodies react with the 130 kDa amber fragment of 
the /3-subunnit in [ 181. 
Only a minor proportion of hybridoma lines 
were found to produce antibodies which are inhibi- 
tory for RNA polymerase. This suggests that most 
antigenic determinants are located in the “scaf- 
folding’ regions of the RNA polymerase molecule 
and only a few are involved in the catalytic func- 
tions of the enzyme. (Some of these functionally 
important sites may be located in cavities inacces- 
sible to antibodies.) 
It should be noted that all inhibitory antibodies 
obtained so far react with antigenic determinants 
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showing a rather low degree of evolutionary con- 
servation: these antibodies do not react with RNA 
polymerase from P. putidu, while almost 50% of 
non-inhibitory antibodies do react with the P. 
putidu enzyme. This result supports our previous 
conclusion, based on experiments with polyclonal 
antibodies, that the catalytic function of most im- 
munogenic sites of the RNA polymerase molecule 
is compatible with a high structural variability 
w41. 
ACKNOWLEDGEMENTS 
We thank Professors R.B. Khesin and 
V.N. Smirnov for their support of the project, 
Dr A. Ibragimov for determining the class of 
immunoglobulins produced by our clones and 
Dr E.S. Kalyaeva for participating in experiments 
with the amber fragment. 
REFERENCES 
[l] Fukuda, R., Ishihama, A., Saitoh, T. and Taketo, 
M. (1977) Mol. Gen. Genet. 154, 135-144. 
[2] Gragerov, AI. and Nikiforov, V.G. (1980) FEBS 
Lett. 122, 17-20. 
[3] Stender, W. (1980) Nucleic Acids Res. 8, 1405- 
1420. 
[4] Kiihler, G. and Milstein, C. (1975) Nature 256, 
495-497. 
]51 
161 
]71 
181 
PI 
WI 
illI 
WI 
]131 
I141 
]151 
]161 
1171 
WI 
Kramer, A., Haars, R., Kabisch, R., Will, H., 
Bautz, F.A. and Bautz, E.K.F. (1980) Mol. Gen. 
Genet. 180, 193-199. 
Christmann, J.L. and Dahmus, M.E. (1981) J. 
Biol. Chem. 256, 11798-11803. 
Carol& S.B. and Stollar, B.D. (1982) Proc. Natl. 
Acad. Sci. USA 79, 7233-7237. 
Burgess, R.R. and Jendrisak, J.J. (1975) Bio- 
chemistry 14, 4634-4639. 
Larionov, O.A., Gragerov, A.I., Kalyaeva, E.S. 
and Nikiforov, V.G. (1979) Mol. Gen. Genet. 176, 
105-111. 
Kearney, J.F., Radbruch, A., Liesegang, B. and 
Rajewsky. K. (1979) J. Immunol. 123, 1548-1550. 
Petrosyan, M.N., Chervonsky, A.V., Ibragimov, 
A.R., Vengerova, T.I., Brondz, B.D. and Rokhlin, 
O.V. (1981) Dokl. Akad. Nauk USSR 256, 509- 
512. 
Heil, A. and Zillig, W. (1970) FEBS Lett. 11, 
165-168. 
Hawkes, R., Niday, E. and Gordon, J. (1982) 
Analyt. Biochem. 119, 142-147. 
Nikiforov, V.G., Lebedev, A.N. and Kalyaeva, 
E.S. (1981) Mol. Gen. Genet. 183, 518-521. 
Gragerov, A.I., Kocherginskaya, S.A., Larionov, 
O.A., Kalyaeva, E.S. and Nikiforov, V.G. (1980) 
Mol. Gen. Genet. 180, 399-403. 
Sverdlov, E.D., Tsarev, S.A. and Kuznetsova, 
N.F. (1980) FEBS Lett. 112, 296-298. 
Chenchik, A., Beabealashvili, R. and Mirzabekov, 
A. (1981) FEBS Lett. 128, 46-50. 
Sever, I.S., Kalyaeva, E.S., Danilevskaya, 0-N. 
and Gorlenko, Zh.M. (1982) Mol. Gen. Genet. 188, 
494-498. 
115 
